The present Invention relates to a compound of formula I [1 - isobutyl - 3 - [2 - [4 - [3 - [4 - [[4 - methyl - 1 - [(2R, 3R, 4S, 5S, 6R) - 3,4,5 - trihidroxi - 6 - (hydroxymethyl) - 2 - tetrahidropiran il] indol-3-yl] methyl] phenoxy] propyl] - 4.9 - diazaspiro [5.5] undecan - 9 - yl] - 2 - oxo - ethyl] urea] or a Salt thereof aceptabl pharmaceutically And, for the treatment of Type 2 diabetesLa presente invencion se refiere a un compuesto de Formula I [1-isobutil-3-[2-[4-[3-[4-[[4-metil-1-[(2R,3R,4S,5S,6R)-3,4,5-trihidroxi-6-(hidroximetil)tetrahidropiran-2-il]indol-3-il]metil]fenoxi]propil]-4,9-diazaspiro[5.5]undecan-9-il]-2-oxo-etil]urea] o una sal del mismo farmaceuticamente aceptable, para el tratamiento de diabetes Tipo 2